Israeli Strikes Kill Dozens of Civilians in Lebanon, Including Christian Official

Abivax Crashes Most On Record After Cancer Cases In Trial Data Spooks Wall Street French biotech Abivax suffered its largest intraday decline on record after reporting new data on its lead experimental inflammatory bowel disease drug, which showed cancer cases among patients in the clinical trial. The new data certainly point to regulatory headwinds and raise the risk profile for approval. Abivax's ABTECT maintenance data showed strong efficacy readout, with both once-daily obefazimod doses meeting the primary endpoint at week 44. Clinical remission rates were 50.8% for the 25 mg dose...

Los Angeles Mayoral Candidates Spar Over Response To Rise In Homelessness Authored by City News Service via The Epoch Times, Mayor Karen Bass and her challenger in the Nov. 3 election, Councilmember Nithya Raman, criticized one another on July 24 over the increase in homelessness in Los Angeles. Homeless tents are seen in the Skid Row area of downtown Los Angeles on June 11, 2026. Apu Gomes/AFP via Getty Images Homelessness increased by 3.4 percent in the city to an estimated 45,194 people, and unsheltered homelessness also rose by nearly 8 percent, according...

Blue Owl Stock Slides After Moody's Cuts Outlook To "Negative" On Surging Redemption Requests Blue Owl stocks is getting slammed this morning, erasing all early gains, after Moody's Ratings cut its outlook on a $36-billion Blue Owl non-traded fund to "negative" from "stable" on Tuesday, citing redemption requests that were significantly higher than at peers in the first quarter. Moody's also said the change in the outlook on Blue Owl Credit Income Corp (OCIC) is ​due to the majority of the redemption requests coming from a very limited number of investors,...